Tymlos 80 MCG dose pen injectr 1.56ML
Ended Awarded
- Contract number
- SPE2DB25FWFCV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,005
Award facts
- Contract value 100% obligated
- $7,005.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $7,005.39 by the Defense Logistics Agency on September 12, 2025, for the supply of TYMLOS 80 MCG Dose Pen Injectr 1.56ML. The delivery order carries an ultimate completion date of September 15, 2025, with no set-aside designation applied to the award. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at approximately $500 million and extending through November 2026.
The DLA, a component of the Department of Defense, utilizes this IDC vehicle to procure a comprehensive range of pharmaceutical products and medical consumables in support of military health facility operations worldwide. TYMLOS (abaloparatide) is a prescription injectable medication used in the treatment of osteoporosis, and this delivery order represents a routine pharmaceutical supply fulfillment from DMS Pharmaceutical Group's established portfolio of branded and generic prescription drugs, biologics, and specialty medications. The vendor's consistent performance as a federal pharmaceutical supplier and woman-owned small business status has positioned it as a key participant in the defense pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FWFCV?
SPE2DB25FWFCV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FWFCV worth?
The government has obligated $7,005 on SPE2DB25FWFCV.
Is contract SPE2DB25FWFCV an order under another contract?
Yes. SPE2DB25FWFCV is a delivery order under SPE2DB25D9320, an indefinite delivery contract.
Was contract SPE2DB25FWFCV competed?
The extent of competition for SPE2DB25FWFCV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award